Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 61 for “"PALB2"”.
-
CRISPR-based studies on BRCA2 and PALB2
… tumour suppressor genes <em>BRCA2</em> and <em>PALB2</em> are among the most common causes of hereditary breast and ovarian cancers. Deleterious mutations in both are also intimately linked to other cancer forms, including pancreatic and prostate cancer. Interestingly, most biallelic germline …
-
Prognostic value of PALB2 expression in pancreatic ductal adenocarcinoma
… tumor suppressor PArtner and Localizer of BRCA2 (PALB2). PALB2 gene mutations are associated with breast and ovary cancer risk, and high PALB2 expression levels associate with poor prognosis in breast cancer. We hypothesized a potential prognostic value of PALB2 expression in pancreatic ductal …
-
Desregulación del splicing del gen PALB2 en cáncer de mama hereditario
… de la desregulación del splicing del gen PALB2 en cáncer de mama hereditario.
-
Comparing Family Sharing Behaviors in <em>BRCA</em> Carriers with <em>PALB2</em> Carriers
… the more recently identified and characterized PALB2 gene. A total of 18 BRCA carriers and 13 PALB2 carriers were interviewed about family sharing practices using a semi-structured guide based on the Integrated Behavioral Model. Barriers and facilitators to family sharing were similar for both …
-
Fanconi Anämie : Entwicklung von hämatopoetischen Mosaiken sowie funktionelle Studien von FANCO (RAD51C) und FANCN (PALB2)
Zur Wahrung der Genomstabilität entwickelten sich verschiedene Reparaturmechanismen, deren Defekte zu diversen Erkrankungen führen. Der 1927 erstmals beschriebenen Fanconi Anämie (FA) (Fanconi 1927) liegt eine fehlerhafte Reparatur der DNA-Doppelstrang-Quervernetzung zugrunde. Als Ursache wurden …
-
Characterisation of the tumour microenvironment in homologous recombination-deficient prostate cancer
… harbour mutations in <em>BRCA2 </em>and <em>PALB2</em>, which are associated with early onset of disease and poor prognosis. There are currently no in vivo immunocompetent models of prostate cancer that explore how deficiencies in homology-directed repair impact the tumour microenvironment …
-
Μελέτη και κλινική αξιολόγηση νέων μοριακών δεικτών καρκίνου του μαστού
Recent reports have included PALB2 (Partner and localizer of BRCA2) in the growinglist of hereditary cancer genes. PALB2 is located in the chromosome region 16p12.1and consists of 13 exons transcribing approximately 3.5Kb mRNA, which encodes aprotein of 1186 amino acids. Exons 4 and 5 are much …
-
Investigating the role of homologous recombination in the maintenance of chromosome stability
… pathway that maintains genome stability. BRCA2, PALB2, and RAD51 are key modulators of this pathway, mutations within which are associated with tumourigenesis. Centromeres are large repetitive DNA regions in the genome, defined through the presence of CENP-A. There is increasing evidence that …
-
Studio del meccanismo di riparazione del DNA nelle leucemie in età pediatrica: alterazioni dei geni NBS1, Fancd2, Palb2 ed espressione dei geni BRCA1 e BRCA2.
… di Fanconi (FA) (BRCA1, BRCA2, FANCD2 e PALB2), che coopera con il gene della sindrome da rottura di Nijmegen (NBS1). Abbiamo voluto la correlazione tra alterazioni del meccanismo di riparazione del DNA e l’insorgenza di recidive e/o con tossicità grave (grado III-IV – CTCAE) durante il …
-
Project 1: Epigenetic analysis of small cell numbers using C-Chip in conjunction with high throughput sequencing AND Project 2: Chracterisation and modelling of mutant PALB2 proteins
… infancy. The FANCN gene, otherwise known as PALB2, was originally described as a FA associated gene in 2006. I describe here work towards an investigation of the role of two mutant PALB2 proteins identified in an unusual FANCN family.
-
The impact of germline genotype on breast cancer tumour phenotype and outcome
… compared between gene carriers (BRCA1+, BRCA2+, PALB2+, CHEK2+, ATM+ and TP53+) and non-carriers. Kaplan Meier analysis was used to estimate differences between carriers and no-carriers for Overall Survival (OS) and Distant Disease-Free Survival (DDFS). A further sample with tumour sequence data …
-
Ανίχνευση νέων αλληλομόρφων σε γονίδια που προδιαθέτουν για τον κληρονομικό καρκίνο
… BRCA2 genes and a maximum of 2.5% in ATM, CHEK2, PALB2, PTEN, TP53, etc. The corresponding percentages for epithelial ovarian cancer range between 20-30% for BRCA1 and BRCA2 and 6-15% for the rest of panel genes. A targeted clinical surveillance and additional preventive measures could be provided …
-
Understanding DNA damage repair inhibitor resistance in homologous recombination deficient breast cancer
… patients with defects in BRCA1, BRCA2 or PALB2 genes, key players in homologous recombination (HR). Understanding the prevalence of distinct mechanisms of resistance to PARPi and cross resistance with Pt in breast cancer may inform therapy choices. Prior pre-clinical work has identified …
-
Molecular causes and consequences of genetic instability with respect to the FA/BRCA Caretaker Pathway
… protein identified downstream of FANCD2 is PALB2. PALB2 was originally discovered as “partner and localizer of BRCA2”. In a candidate gene approach we tested patients with early childhood cancers but without mutations in BRCA2 for mutations in PALB2 (publication 6). PALB2 was identified as a …
-
Identification of low-penetrance alleles, genetic modifiers and mutation analysis in familial breast cancer cases
… the role of the two Fanconi Anemia (FA) genes <i>PALB2</i> and <i>SLX4</i> as breast cancer predisposing loci. In the <i>PALB2</i> screening, I observed a frequency of deleterious mutation of 2.1 % in familial cases recruited in cancer centers in Milan. Interestingly, I also identified the …
-
A STUDY OF THE BRCA1 COILED-COIL REGION IN MOUSE DEVELOPMENT, TUMOR SUPPRESSION, AND DRUG RESISTANCE.
… by enabling the formation of the larger BRCA1-PALB2-BRCA2 complex trough its coiled-coil region. Although BRCA1 functions in both HR steps, its essential role in each step is unclear, with previous reports showing that RAD51 loading after DNA end resection occurred could be BRCA1 independent. …
-
Integrative Analysis to Evaluate Similarity Between BRCAness Tumors and BRCA Tumors
… patients and patients with germline mutations in PALB2, RAD51B, and RAD51C, genes that are key parts of the HRR pathway and that interact with BRCA1/2. Our findings suggest that the BRCAness category does have biological and clinical relevance but that the criteria for including patients in this …
-
Economic Evaluation of Prevention Strategies for Women at Increased Risk of Breast and Ovarian Cancer
… newer moderate penetrance genes such as PALB2, RAD51C, RAD51D, and BRIP1. BC screening, medical prevention, and risk-reducing surgery are recommended risk management strategies. Surgical prevention, including risk reducing mastectomy (RRM) for BC and risk-reducing salpingo-oophorectomy …
-
Regulación del splicing alternativo y aberrante en genes de reparación del ADN y susceptibilidad hereditaria a cáncer de mama/ovario
… genes: ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, RAD51C, and RAD51D. The use of high-throughput sequencing techniques to identify deleterious variants in these genes has markedly increased the detection of variants of uncertain clinical significance (VUS). Many of these variants can disrupt …
Page 1 of 4